This website uses cookies and similar technologies (hereinafter collectively referred to as ‘cookies’). We may use cookies for the following purposes:
With the buttons below, you can choose which cookies you wish to accept. On our cookie statement page, you can manage your cookie preferences. You can always withdraw your consent for cookies by making different choices there. For more information about cookies, please refer to our cookie statement.
Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the appointments of Jeltje Schulten, M.D., MBA, as SVP of clinical and medical affairs
Read the article: https://www.bioqubeventures.com/bicara-therapeutics-expands-clinical-team-with-appointments-of-jeltje-schulten-m-d-mba-as-svp-of-clinical-and-medical-affairs-and-rita-dalal-mbbs-mph-as-vp-of-clinical-development/